Vivani Medical (VANI) Research & Development (2014 - 2026)
Vivani Medical (VANI) posted quarterly Research & Development of $4.4 million for Q1 2026, up 4.1% year-over-year from $4.2 million in Q1 2025, and up 273.62% quarter-over-quarter from $1.2 million in Q4 2025.
Vivani Medical (VANI) Research & Development (2014 - 2026) Analysis & Trends
Vivani Medical's Research & Development history runs 12 years deep, the most recent figure standing at $4.4 million for Q1 2026.
- In Q1 2026, Research & Development rose 4.1% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $7.9 million (down 38.38% YoY), while the FY2025 annual figure was $4.3 million, down 72.51% from the prior year.
- Research & Development for Q1 2026 stood at $4.4 million, up from $1.2 million in the prior quarter.
- The five-year high for Research & Development was $4.7 million in Q4 2023, with the low at $748000.0 in Q1 2024.
- The 5-year median for Research & Development is $3.9 million (2022), against an average of $3.1 million.
- The sharpest annual moves came in 2022 and 2024: Research & Development soared 702.1% in 2022, then slumped 82.62% in 2024.
- Vivani Medical's Research & Development stood at $4.4 million in 2022, then climbed by 6.35% to $4.7 million in 2023, then fell by 8.6% to $4.3 million in 2024, then sank by 72.69% to $1.2 million in 2025, then soared by 273.62% to $4.4 million in 2026.
- Business Quant data shows VANI's Research & Development at $4.4 million in Q1 2026, $1.2 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 413.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -588.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 210.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 97.90 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 4.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.46 Mn |
| Mar 31, 2026 | 4.39 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Sep 30, 2024 | 772,000.00 |
| Jun 30, 2024 | 3.51 Mn |
| Mar 31, 2024 | 748,000.00 |
| Dec 31, 2023 | 4.71 Mn |
| Sep 30, 2023 | 4.44 Mn |
| Jun 30, 2023 | 3.86 Mn |
| Mar 31, 2023 | 3.96 Mn |
| Dec 31, 2022 | 4.43 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 3.20 Mn |
| Mar 31, 2022 | 2.68 Mn |
| Dec 31, 2021 | 2.98 Mn |
| Sep 30, 2021 | 2.87 Mn |